MDGL- Madrigal Pharmaceuticals, Inc.

Name: Madrigal Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Madrigal Pharmaceuticals, Inc. (MDGL) has 11 insiders with recent SEC Form 4 filings, including 5 buys and 9 sells. MDGL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Taub Rebecca	452.2K	$231.67M	-
Dir	Friedman Paul A	199.7K	$102.29M	-
Dir	Baker Bros. Advisors LP	199.7K	$102.28M	-
CEO	Sibold William John	150.1K	$76.88M	-
Dir	Levy Richard S	27.3K	$14.00M	-

Activity

Buys and sells only

Transactions

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Nov 21, 2018	Milligan David V	Director	Sell	20,000	$112.54	$2,250,800.00	-100%
Nov 20, 2018	Friedman Paul A	Chief Executive Officer	Buy	4,000	$117.88	$471,520.00	+2.5%
Nov 19, 2018	Milligan David V	Director	Sell	10,000	$131.60	$1,316,000.00	-33.3%
Nov 19, 2018	Craves Fred B	Director, 10% Owner	Buy	2,000	$124.69	$249,387.00	+0.2%
Nov 19, 2018	Friedman Paul A	Chief Executive Officer	Buy	4,000	$124.00	$496,000.00	+2.6%
Jun 11, 2018	Schneebaum Marc R	Chief Financial Officer	Sale+OE	10,099	$287.46	$2,903,058.54	-19.5%
Jun 11, 2018	Bay City Capital LLC	Director, 10% Owner	Sell	280,000	$287.46	$80,488,800.00	-4.9%
Jun 11, 2018	Friedman Paul A	Chief Executive Officer	Sell	73,526	$287.46	$21,135,783.96	-10.1%
Jun 11, 2018	Taub Rebecca	Chief Medical Officer, EVP R&D	Sell	73,526	$287.46	$21,135,783.96	-10.1%
Jun 11, 2018	Craves Fred B	Director, 10% Owner	Sell	280,000	$287.46	$80,488,800.00	-4.9%

← PrevPage 9Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC